FT : PAI Partners strikes €330mn deal for Italian haircare group Beautynova

PAI Partners strikes €330mn deal for Italian haircare group Beautynova
Private equity group will acquire majority stake from Bluegem as beauty market remains buoyant

French private equity group PAI Partners is to buy a majority stake in professional hair products maker Beautynova as it seeks to capitalise on the buoyant beauty market. 

Paris-based PAI will acquire a 51 per cent stake in Beautynova for about €330mn from consumer-focused private equity firm Bluegem.

Bluegem, which originally bought its 79 per cent stake in 2020 for €52mn, will sell its position to PAI and then buy back in for about 47 per cent.

Milan-based Beautynova brands include Medavita and Urban Tribe. The company also develops haircare products aimed at professionals for treatments, colouring and styling, with 18,000 formulas so far.  

It had sales of €130mn in 2023 and earnings before interest, taxes, depreciation and amortisation of €30mn — valuing the company at a multiple of 11 to 12 times ebitda. 

“Beautynova has evolved into a leading professional haircare platform, more than tripling its sales and experiencing substantial geographical expansion, with a particular focus on the US,’’ the private equity firms said in a statement on Monday. They plan to accelerate the growth of Beautynova across the US and Europe.

The deal is the latest in a string of mooted transactions in the beauty sector after private equity-owned German beauty retailer Douglas announced earlier this month plans to list in Frankfurt. Spanish luxury and beauty group Puig, which owns brands including Paco Rabanne and Charlotte Tilbury, said at the end of 2023 that it would explore a listing. 

Following the transaction, Bluegem will retain a 47 per cent stake in the beauty company with the remaining 2 per cent held by Beautynova’s management.

The environment for private equity exits has been tough on both sides of the Atlantic as rising interest rates and market volatility have severely curtailed the market for listings. A report by consultancy Bain said private equity groups globally were sitting on a record 28,000 unsold companies worth more than $3tn.

However, the announcement of the Douglas listing, as well as Puig’s plans and UK buyout firm Permira’s exploration of a listing for luxury Italian sports shoe company Golden Goose, has raised hopes that the market is regaining momentum in Europe. 

At the same time, demand for beauty products remains buoyant globally despite pressures on household spending and an uncertain outlook in China, the sector’s fastest-growing market. In the US — beauty’s biggest market — sales of high-end hair products were the fastest-growing category last year, with dollar sales up 24 per cent, according to consumer research company Circana. 

Deals for beauty companies that cater to higher-spending consumers fetched substantial price tags last year despite the more subdued global dealmaking environment. French luxury group Kering’s€3.5bn acquisition of fragrance brand Creed fetched a multiple of about 23 times ebitda, while L’Oréal snapped up Aesop — the minimalist maker of high-end soaps — in a $2.5bn deal. 

L’Oréal’s specialist beauty division, which caters to professionals and is largely focused on haircare, delivered €4.6bn in sales after growing 7.6 per cent on a like-for-like basis last year. 

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • NIU -4.5%, LEGH -2.5%, SAIC -1.9%
Other news:
  • RILY -10.6% (disclosed late filing update)
  • LOGI -5.5% (CFO to depart company)
  • ADCT -5% (files for 4,412,840 share common stock offering by selling shareholders)
  • NEWT -3.8% (to delay 10-K filing)
  • SRG -2.5% (to delay 10-K filing)
  • MOND -2.3% (to delay 10-K filing)
  • AMTX -1.6% (to delay 10-K filing)
  • HLN -1.4% (Pfizer (PFE) proposes secondary global offering and proposed share buyback)
  • SN -1.3% (announces launch of secondary offering of ordinary shares)
  • EXLS -1% (entered into a master confirmation as part of the Company's previously announced $500 million common stock repurchase program)
  • HTZ -0.8% (CEO Stephen Scherr to step down; Gil West, former COO of Delta Airlines (DAL) and GM's (GM) Cruise unit, will become CEO effective April 1)
Analyst comments:
  • NYCB -1.3% (downgraded to Underperform from Mkt Perform at Raymond James)
  • AIRC -0.9% (downgraded to Mkt Perform from Outperform at Raymond James)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • QD +5.2%, ERJ +4.5%, MNTX +3.1%
Other news:
  • NVEI +29% (responds to recent press reports speculating as to a potential going-private transaction)
  • GOEV +13.4% (announced that the U.S. Department of Commerce has approved its Oklahoma City facility as a Foreign Trade Zone)
  • VERI +13.4% (to delay 10-K filing)
  • HCP +10% (report it has been considering options including a sale, according to Bloomberg)
  • FENC +6.2% (Fennec Pharmaceuticals and Norgine enter into exclusive licensing agreement to commercialize PEDMARQSI in Europe, Australia, and New Zealand)
  • LVO +4.3% (provides update for March)
  • WEST +3.9% (entered into Equity Distribution Agreement not to exceed 5 mln shares of Common Stock)
  • FF +3.8% (provides update on $2.50 per share special cash dividend)
  • CSTL +3.4% (New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older)
  • TSLA +3.2% (Elon Musk says Model Y price will rise by $1000 in a few weeks)
  • BEP +3% (files mixed securities shelf offering)
  • PHVS +3% (announces phase 3 clinical study design for recently initiated RAPIDe-3 Study, and presents quality-of-life improvement and caregiver behavior data at Two Recent HAE Congresses)
  • KALV +2.8% (presents real-world data on burden of treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas)
  • OPTN +2.1% (following trading halt on Friday)
  • VVI +2% (files mixed shelf securities offering)
  • AVXL +2% (announces that the first patient in its U.S. FDA cleared placebo-controlled Phase 2 clinical study of ANAVEX3-71 for the treatment of schizophrenia has been screened ahead of schedule)
  • DWAC +1.3% (entered into an amendment to the Warrant Agreement in connection with the Business Combination, on March 15)
  • PBR +1.2% (clarifies pieces of news in the media)
  • HMC +1.2% (sign MOU with Nissan to collaborate on Evs)

>>> US Research Calls V1

Research Calls
  • Upgrades:
    • Futu Holdings (FUTU) upgraded to Outperform from Underperform at CLSA; tgt raised to $65
    • Globus Medical (GMED) upgraded to Buy from Neutral at BTIG Research; tgt $60
    • PepsiCo (PEP) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $190
    • Pinnacle West (PNW) upgraded to Buy from Neutral at BofA Securities; tgt raised to $80
    • Regions Fincl (RF) upgraded to Buy from Neutral at Citigroup; tgt raised to $23
    • Ventas (VTR) upgraded to Outperform from In-line at Evercore ISI; tgt $50
  • Downgrades:
    • Apartment Income REIT Corp. (AIRC) downgraded to Mkt Perform from Outperform at Raymond James
    • Invitation Homes (INVH) downgraded to In-line from Outperform at Evercore ISI; tgt $36
    • New York Community (NYCB) downgraded to Underperform from Mkt Perform at Raymond James; tgt $3
    • NIKE (NKE) downgraded to Sell from Hold at Williams Trading
    • Prologis (PLD) downgraded to In-line from Outperform at Evercore ISI; tgt $136
    • SL Green Realty (SLG) downgraded to Underperform from In-line at Evercore ISI; tgt $44
    • Terex (TEX) downgraded to Neutral from Overweight at JP Morgan; tgt $63
  • Others:
    • Ball Corp (BALL) initiated with an Equal-Weight at Morgan Stanley; tgt $68
    • Howmet Aerospace (HWM) initiated with an Outperform at RBC Capital Mkts; tgt $75
    • Medpace (MEDP) initiated with a Hold at Deutsche Bank; tgt $395
    • Welltower (WELL) initiated with an Outperform at Exane BNP Paribas; tgt $104

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • NVEI +16.1%, HCP +11.2%, FENC +8%, OPTN +4.3%, LVO +4.3%, FF +4%, WEST +3.9%, GOEV +3.6%, QD +3.6%, CSTL +3.4%, TSLA +3.3%, MNTX +3.1%, BEP +3%, KALV +2.8%, VVI +2%, CCI +2%, PWFL +1.9%, INSE +1.8%, HMC +1.7%, PBR +1.2%, DWAC +1.1%, PRCH +0.9%
  • Gapping down:
    • RILY -10.7%, LOGI -7.8%, NIU -4.5%, SRG -2.5%, LEGH -2.5%, SN -2.4%, MOND -2.3%, HLN -2.2%, AMTX -1.6%, ADCT -0.8%, CSL -0.6%

>>> Europe : Brokers Upgrades & Downgrades - 18th of March 2024 V3(++)

>>> Up
* Aalberts Raised to Buy at Bank Degroof Petercam (++)
* Alisa Pankki Oyj Raised to Reduce at Inderes; PT 15 euro cents
* Alstom Raised to Buy at Deutsche Bank (+)
* Aston Martin Raised to Buy at BofA; PT 250 pence (+)
* Beazley PT Raised to 975 pence from 775 pence at RBC
* Covivio Raised to Buy at HSBC; PT 52 euros
* Datalogic Raised to Buy at Intesa Sanpaolo; PT 6.90 euros (+)
* E.On Raised to Equal-Weight at Morgan Stanley; PT 15 euros
* Infotel Raised to Buy at Euroland Corporate; PT 54 euros
* Italgas Raised to Neutral at Grupo Santander; PT 5.50 euros (+)
* MVISE Raised to Speculative Buy at SMC Research; PT 1.60 euros (+)
* Nvidia PT Raised to $1,177 from $911 at Truist Secs (++)
* PepsiCo Raised to Overweight at Morgan Stanley; PT $190
* PZ Cussons Raised to Buy at Numis; PT 141 pence (+)
* Redeia Raised to Buy at Bestinver; PT 16.50 euros (+)
* Rentokil Raised to Outperform at BNPP Exane; PT 620 pence
* Signify Raised to Overweight at Barclays; PT 32 euros
* Systemair Raised to Buy at Jefferies; PT 85 kronor

>>> Down
* Aena Cut to Hold at Jefferies; PT 188 euros
* Bytes Technology Cut to Hold at Numis; PT 585 pence (+)
* Centrica Cut to Sector Perform at RBC; PT 145 pence
* EDP Renovaveis Cut to Hold at SocGen; PT 14.30 euros
* Gecina Cut to Hold at HSBC; PT 105 euros
* Meyer Burger Cut to Neutral at Goldman; PT 0.07 Swiss francs
* Nike Cut to Sell at Williams Trading; PT $85
* Nike PT Cut to $120 from $140 at Telsey (++)
* OHL Cut to Hold at SocGen; PT 38 euro cents (+)
* Reckitt Raised to Outperform at BNPP Exane; PT 5,300 pence (+)
* Richemont Cut to Market Perform at ZKB (+)
* Vidrala Cut to Underperform at Oddo BHF (+)

>>> Initiation
* C3.ai Rated New Underperform at Baptista Research; PT $29.70
* JM Re-Initiated Buy at Danske Bank Markets; PT 250 kronor (+)
* NCC Reinstated Hold at Danske Bank Markets; PT 160 kronor (++)
* Renk Group Rated New Neutral at Citi; PT 28.50 euros
* Renk Group Rated New Neutral at Goldman; PT 25.90 euros
* Renk Group Rated New Outperform at Oddo BHF; PT 30.50 euros
* Renk Group Rated New Hold at Kepler Cheuvreux; PT 27 euros (++)
* Swedish Logistic Property Rated New Buy at ABG; PT 35 kronor
* Telecom Plus Rated New Buy at Investec; PT 2,197 pence
* Viasat Rated New Buy at Baptista Research; PT $25.30
* Webrock Ventures Rated New Buy at Pareto Securities (++)

>>> Call
* Aena Strategy Reflected in Consensus, Jefferies Cuts to Hold
* Alstom Jumps as Deutsche Bank Upgrades to Buy on Optimism (++)
* Beazley Ready for a Re-Rating, PT Lifted to Street-High at RBC
* Centrica Downgraded at RBC on Lack of Upcoming Catalysts
* E.On Upgraded at Morgan Stanley on Much Better Growth Guidance
* JPMorgan’s Matejka Closes Preference for US Stocks Over Europe
* Lancashire Gains as BofA Lifts to Buy on Better Business Mix (++)
* Morgan Stanley’s Wilson Says Stocks Nearing Crucial Rates Test (+)
* Oppenheimer AM Sees Some Buying Opportunity in Stocks Pullback (+)
* Reckitt Cash Returns at Risk on Formula Litigation: Jefferies
* Richemont Falls as ZKB Cuts on Risk of Baseline Disappointment (++)
* Signify Double-Upgraded at Barclays on Compelling Risk-Reward (++)
* Systemair Raised at Jefferies, Positioned For Market Trends

>>> Europe : Brokers Upgrades & Downgrades - 18th of March 2024 V2(+)

>>> Up
* Alisa Pankki Oyj Raised to Reduce at Inderes; PT 15 euro cents
* Alstom Raised to Buy at Deutsche Bank (+)
* Aston Martin Raised to Buy at BofA; PT 250 pence (+)
* Beazley PT Raised to 975 pence from 775 pence at RBC
* Covivio Raised to Buy at HSBC; PT 52 euros
* Datalogic Raised to Buy at Intesa Sanpaolo; PT 6.90 euros (+)
* E.On Raised to Equal-Weight at Morgan Stanley; PT 15 euros
* Infotel Raised to Buy at Euroland Corporate; PT 54 euros
* Italgas Raised to Neutral at Grupo Santander; PT 5.50 euros (+)
* MVISE Raised to Speculative Buy at SMC Research; PT 1.60 euros (+)
* PepsiCo Raised to Overweight at Morgan Stanley; PT $190
* PZ Cussons Raised to Buy at Numis; PT 141 pence (+)
* Redeia Raised to Buy at Bestinver; PT 16.50 euros (+)
* Rentokil Raised to Outperform at BNPP Exane; PT 620 pence
* Signify Raised to Overweight at Barclays; PT 32 euros
* Systemair Raised to Buy at Jefferies; PT 85 kronor

>>> Down
* Aena Cut to Hold at Jefferies; PT 188 euros
* Bytes Technology Cut to Hold at Numis; PT 585 pence (+)
* Centrica Cut to Sector Perform at RBC; PT 145 pence
* EDP Renovaveis Cut to Hold at SocGen; PT 14.30 euros
* Gecina Cut to Hold at HSBC; PT 105 euros
* Meyer Burger Cut to Neutral at Goldman; PT 0.07 Swiss francs
* Nike Cut to Sell at Williams Trading; PT $85
* OHL Cut to Hold at SocGen; PT 38 euro cents (+)
* Reckitt Raised to Outperform at BNPP Exane; PT 5,300 pence (+)
* Richemont Cut to Market Perform at ZKB (+)
* Vidrala Cut to Underperform at Oddo BHF (+)

>>> Initiation
* C3.ai Rated New Underperform at Baptista Research; PT $29.70
* JM Re-Initiated Buy at Danske Bank Markets; PT 250 kronor (+)
* Renk Group Rated New Neutral at Citi; PT 28.50 euros
* Renk Group Rated New Neutral at Goldman; PT 25.90 euros
* Renk Group Rated New Outperform at Oddo BHF; PT 30.50 euros
* Swedish Logistic Property Rated New Buy at ABG; PT 35 kronor
* Telecom Plus Rated New Buy at Investec; PT 2,197 pence
* Viasat Rated New Buy at Baptista Research; PT $25.30

>>> Call
* Aena Strategy Reflected in Consensus, Jefferies Cuts to Hold
* Beazley Ready for a Re-Rating, PT Lifted to Street-High at RBC
* Centrica Downgraded at RBC on Lack of Upcoming Catalysts
* E.On Upgraded at Morgan Stanley on Much Better Growth Guidance
* JPMorgan’s Matejka Closes Preference for US Stocks Over Europe
* Morgan Stanley’s Wilson Says Stocks Nearing Crucial Rates Test (+)
* Oppenheimer AM Sees Some Buying Opportunity in Stocks Pullback (+)
* Reckitt Cash Returns at Risk on Formula Litigation: Jefferies
* Signify Double-Upgraded at Barclays on Compelling Risk-Reward (+)
* Systemair Raised at Jefferies, Positioned For Market Trends

>>> Stoxx 600 Pre-Market Indications

  • Novonesis (Novozymes) B (NZM2 TH) +3.8%
  • Rentokil (RTO1 TH) +3.2%
    • Rentokil Raised to Outperform at BNPP Exane; PT 620 pence
  • Ubisoft (UEN TH) +1.8%
  • BAE (BSP TH) +1.7%
  • Rheinmetall (RHM TH) +1.6%
  • Intesa Sanpaolo (IES TH) +1.3%
  • Nordea Bank (04Q TH) +1.2%
  • Alstom (AOMD TH) +1.2%
    • Alstom Raised to Buy at Deutsche Bank
  • Aena (A44 TH) -0.9%
    • Aena Strategy Reflected in Consensus, Jefferies Cuts to Hold
  • Mowi (PND TH) -1%
  • Ryanair (RY4C TH) -1.4%
    • Boeing’s Pain Spreads to Travelers as Airlines Cut Back on Plans
  • Nokia (NOA3 TH) -1.8%
  • UCB (UNC TH) -3%
  • Haleon (H6D0 TH) -3.9%
    • Pfizer Plans to Sell About £2 Billion of Shares in Haleon